Jim Klostergaard

2.9k total citations
110 papers, 2.4k citations indexed

About

Jim Klostergaard is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jim Klostergaard has authored 110 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 37 papers in Immunology and 28 papers in Oncology. Recurrent topics in Jim Klostergaard's work include Immune Response and Inflammation (22 papers), Sphingolipid Metabolism and Signaling (13 papers) and Lipid Membrane Structure and Behavior (12 papers). Jim Klostergaard is often cited by papers focused on Immune Response and Inflammation (22 papers), Sphingolipid Metabolism and Signaling (13 papers) and Lipid Membrane Structure and Behavior (12 papers). Jim Klostergaard collaborates with scholars based in United States, Japan and China. Jim Klostergaard's co-authors include Mien‐Chie Hung, Sukhen C. Ghosh, Ping Tang, Edmond J. Auzenne, Gabriel Lopez‐Berestein, Michele LeRoux, Toshihiko Utsumi, S. Neslihan Alpay, Gale A. Granger and Kunihiro Akimaru and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jim Klostergaard

109 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jim Klostergaard United States 29 1.2k 598 496 296 273 110 2.4k
Walker Wharton United States 27 1.9k 1.6× 365 0.6× 921 1.9× 257 0.9× 242 0.9× 74 3.5k
Srikumar M. Raja United States 27 1.3k 1.1× 684 1.1× 359 0.7× 173 0.6× 315 1.2× 37 2.4k
Yasuo Kubota Japan 27 1.4k 1.1× 432 0.7× 294 0.6× 156 0.5× 630 2.3× 149 3.3k
Hiroaki Kodama Japan 32 2.3k 1.9× 803 1.3× 1.0k 2.1× 152 0.5× 417 1.5× 110 4.1k
Lucas L. Colombo Argentina 23 810 0.7× 296 0.5× 424 0.9× 138 0.5× 155 0.6× 76 2.0k
Lou de Leij Netherlands 23 1.0k 0.8× 380 0.6× 483 1.0× 153 0.5× 158 0.6× 51 1.9k
Wen Chen China 26 1.9k 1.6× 674 1.1× 534 1.1× 144 0.5× 266 1.0× 75 3.0k
Guobo Shen China 27 1.6k 1.3× 778 1.3× 681 1.4× 166 0.6× 160 0.6× 74 3.2k
Douglas Lazarus United States 20 1.5k 1.2× 404 0.7× 774 1.6× 158 0.5× 168 0.6× 38 2.7k
Thilo Spruß Germany 31 1.6k 1.3× 290 0.5× 1.4k 2.9× 276 0.9× 296 1.1× 80 3.7k

Countries citing papers authored by Jim Klostergaard

Since Specialization
Citations

This map shows the geographic impact of Jim Klostergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Klostergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Klostergaard more than expected).

Fields of papers citing papers by Jim Klostergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Klostergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Klostergaard. The network helps show where Jim Klostergaard may publish in the future.

Co-authorship network of co-authors of Jim Klostergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Klostergaard. A scholar is included among the top collaborators of Jim Klostergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Klostergaard. Jim Klostergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aşkan, Gökçe, et al.. (2019). Precision medicine for metastatic colorectal cancer: an evolving era. Expert Review of Gastroenterology & Hepatology. 13(10). 919–931. 35 indexed citations
2.
Lee, Sun Joo, Sukhen C. Ghosh, Hee Dong Han, et al.. (2012). Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma. Clinical Cancer Research. 18(15). 4114–4121. 36 indexed citations
3.
Ghosh, Sukhen C., S. Neslihan Alpay, & Jim Klostergaard. (2012). CD44: a validated target for improved delivery of cancer therapeutics. Expert Opinion on Therapeutic Targets. 16(7). 635–650. 103 indexed citations
4.
Galer, Chad E., Daisuke Sano, Sukhen C. Ghosh, et al.. (2011). Hyaluronic acid–paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism. Oral Oncology. 47(11). 1039–1047. 33 indexed citations
5.
LeRoux, Michele, Edmond J. Auzenne, Sukhen C. Ghosh, et al.. (2009). MRP- and BCL-2-mediated drug resistance in human SCLC: Effects of apoptotic sphingolipids in vitro. Lung Cancer. 66(1). 48–57. 7 indexed citations
6.
Ghosh, Sukhen C., et al.. (2008). N,N-Dimethylsphingosine conjugates of poly-l-glutamic acid: Synthesis, characterization, and initial biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19(3). 1012–1017. 3 indexed citations
7.
Klostergaard, Jim, Edmond J. Auzenne, Sukhen C. Ghosh, et al.. (2006). Magnetic resonance imaging-based prospective detection of intraperitoneal human ovarian carcinoma xenografts treatment response. International Journal of Gynecological Cancer. 16(S1). 111–117. 9 indexed citations
8.
Donato, Nicholas J. & Jim Klostergaard. (2004). Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells. Experimental Cell Research. 294(2). 523–533. 25 indexed citations
9.
Utsumi, Toshihiko, Kenji Tanaka, Kenji Takami, et al.. (2001). Transmembrane TNF (pro‐TNF) is palmitoylated. FEBS Letters. 500(1-2). 1–6. 38 indexed citations
10.
Mehta, Shashi, et al.. (2000). Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemotherapy and Pharmacology. 46(2). 85–92. 59 indexed citations
11.
Mujoo, Kalpana, Lenan Zhang, Jim Klostergaard, & Nicholas J. Donato. (2000). Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacement. International Journal of Gynecological Cancer. 10(2). 105–114. 16 indexed citations
12.
Ishisaka, Rumi, Naoko Sato, Keisuke Tanaka, et al.. (1999). A Part of the Transmembrane Domain of pro-TNF Can Function as a Cleavable Signal Sequence That Generates a Biologically Active Secretory Form of TNF. The Journal of Biochemistry. 126(2). 413–420. 9 indexed citations
13.
Lengyel, Ernst, Jim Klostergaard, & Douglas D. Boyd. (1995). Stimulation of urokinase expression by TNF-α requires the activation of binding sites for the AP-1 and PEA3 transcription factors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1268(1). 65–72. 25 indexed citations
14.
Auzenne, Edmond J., et al.. (1995). Tetramodality treatment of human melanoma in vitro. Melanoma Research. 5(1). 49–57. 1 indexed citations
15.
Lodato, Robert F., Barry W. Feig, Kunihiro Akimaru, Gen‐Ichiro Soma, & Jim Klostergaard. (1995). Hemodynamic Evaluation of Recombinant Human Tumor Necrosis Factor (TNF)-α, TNF-SAM2 and Liposomal TNF-SAM2 in an Anesthetized Dog Model. Journal of Immunotherapy. 17(1). 19–29. 10 indexed citations
16.
Story, Michael D., et al.. (1994). Cytotoxic manifestations of the interaction between hyperthermia and TNF: DNA fragmentation. International Journal of Hyperthermia. 10(2). 247–262. 12 indexed citations
17.
Ohno, Shinji, F. R. Strebel, L. Clifton Stephens, et al.. (1992). Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.. PubMed. 52(15). 4096–101. 14 indexed citations
18.
Utsumi, Toshihiko, Jim Klostergaard, Kunihiro Akimaru, et al.. (1992). Modulation of TNF-α-priming and stimulation-dependent superoxide generation in human neutrophils by protein kinase inhibitors. Archives of Biochemistry and Biophysics. 294(1). 271–278. 74 indexed citations
19.
Akimaru, Kunihiro, Toshihiko Utsumi, Eisuke F. Sato, et al.. (1992). Role of tyrosyl phosphorylation in neutrophil priming by tumor necrosis factor-α and granulocyte colony stimulating factor. Archives of Biochemistry and Biophysics. 298(2). 703–709. 55 indexed citations
20.
Tomasovic, Stephen P. & Jim Klostergaard. (1989). Hyperthermic modulation of macrophage-tumor cell interactions. Cancer and Metastasis Reviews. 8(3). 215–229. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walker Wharton Breakdown of academic impact, for papers by Srikumar M. Raja Breakdown of academic impact, for papers by Yasuo Kubota Breakdown of academic impact, for papers by Hiroaki Kodama Breakdown of academic impact, for papers by Lucas L. Colombo Breakdown of academic impact, for papers by Lou de Leij Breakdown of academic impact, for papers by Wen Chen Breakdown of academic impact, for papers by Guobo Shen Breakdown of academic impact, for papers by Douglas Lazarus Breakdown of academic impact, for papers by Thilo Spruß
Rankless by CCL
2026